Left: Structure of the Human Immunodeficiency Virus (HIV). Note the envelope protein that protects the virus against immunological detection and the small genome consisting of two short strands of RNA ...

Left: Structure of the Human Immunodeficiency Virus (HIV). Note the envelope protein that protects the virus against immunological detection and the small genome consisting of two short strands of RNA ...

A few months into his postdoctoral research at Baylor College of Medicine in 2021, Rafael Michita made a curious observation. Peering at Zika viruses infiltrating placenta cells under a microscope, he ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible for ...

At the cellular level, HIV-1 transmission involves a highly coordinated process whereby the virus binds to CD4 receptors and one of two coreceptors—CCR5 (R5) or CXCR4 (X4)—on host immune cells, ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, researchers have now identified a perineural pathway through which the HIV virus ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

HIV spreads through direct contact with the bodily fluids of infected individuals. Once individuals are infected, HIV particles target our T cells, a type of white blood cell. Healthy T cells identify ...

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in ...

Explore the latest advancements in HIV therapy and how enhanced immune cells can improve treatment outcomes for patients.